Activist investor Ananym Capital Management plans to nominate as many as half a dozen directors to the board at Henry Schein ...
Ananym Capital Management, an activist investor, has plans to nominate up to six directors to the board of Henry Schein ...
Jefferies raised the firm’s price target on Henry Schein (HSIC) to $80 from $77 and keeps a Hold rating on the shares. Management has a strong ...
The Acentus transaction follows Henry Schein’s acquisition of Prism Medical Products, LLC in 2021 and Shield Healthcare and ...
Henry Schein, Inc. (Nasdaq: HSIC) reminds its customers throughout California that the Henry Schein Customer Emergency Support Hotline is open for dental and medical professionals who may experience ...